Polygodial: A Causal Framework for TRPA1 Research
2026-08-29
Polygodial is a TRPA1 channel activator for connecting ion-channel activity with calcium signaling and cellular phenotype. This article presents a causality-first framework for designing, interpreting, and troubleshooting TRPA1 experiments across neuronal and epithelial models.
TSA, ERK/FoxO3a, and Autophagic Flux in Pancreatitis
2026-08-28
The reference study identifies the ERK/FoxO3a axis as a mechanistic link between trichostatin A treatment and restoration of impaired autophagic flux in acute pancreatitis. By combining network pharmacology with cell-based perturbation and rat validation, it connects pathway regulation with reduced inflammatory injury while also defining important limits for causal interpretation.
Neuroligin 1 Proteolysis Sustains Social Memory
2026-08-28
The reference study identifies social interaction-induced cleavage of Neuroligin 1 as a mechanism that maintains, rather than merely forms, short-term social memory. Its combination of secretase perturbation, NLG1 genetics, cofilin analysis, spine imaging, and Tat-PBD rescue connects extracellular social cues to intracellular synaptic remodeling in the ventral hippocampus.
Metoprolol Tartrate in β1 Research
2026-08-27
Metoprolol Tartrate enables selective β1-adrenergic receptor inhibition across cardiomyocyte, cardiovascular, and hematopoietic regeneration assays. Its contrast with nonselective β-blockade helps researchers separate cardiac β1 mechanisms from broader adrenergic effects and improve experimental interpretation.
Drug Response Metrics in Cancer: Schwartz Dissertation
2026-08-27
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but not interchangeable drug-response measures. Its main practical contribution is a more discriminating framework for interpreting endpoint data, especially when treatment-induced arrest and killing occur on different schedules.
LY2109761: TGF-β Pathway Research Workflows
2026-08-26
LY2109761 enables controlled interrogation of TGF-β-driven Smad signaling, invasion, fibrosis, and radiation response. This workflow-focused guide shows how to connect receptor inhibition with mechanistic validation and phenotype-level assays while avoiding common dosing, vehicle, and interpretation errors.
RapaLink-1: Mechanism, Assays, and Dormancy
2026-08-26
RapaLink-1 is a third-generation mTOR inhibitor whose bivalent binding strategy addresses resistance to earlier mTOR kinase inhibitors. This guide translates its cancer-model evidence and the latest mTOR-dependent dormancy protocol into an evidence-gated framework for designing reproducible assays.
Phosbind Acrylamide for Mechanistic Phospho-Analysis
2026-08-25
Phosbind Acrylamide enables antibody-independent protein phosphorylation analysis through phosphate-dependent mobility shifts in SDS-PAGE. This article presents a decision framework for applying the reagent to pathway studies, using DNA-PKcs-driven kidney fibrosis to clarify assay opportunities, controls, and limitations.
Standardized Whole-Blood Immunometabolism Assays
2026-08-25
Zhao and colleagues present a standardized whole-blood stimulation protocol that combines defined immune challenges with pharmacological metabolism modulation and cytokine measurement. Its main value is methodological: it provides a reproducible, cohort-compatible framework for testing how anabolic and catabolic pathways selectively shape human immune responses.
Hydroxychloroquine Sulfate: Workflow Guide
2026-08-24
Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible reagent for autoimmune disease research involving autophagy pathway modulation and TLR7/9-linked signaling. It is suited to short-term, water-based cellular or animal-model workflows, but is not appropriate for protocols requiring DMSO, ethanol, or long-term storage of prepared solutions.
T-5224 for AP-1 Inflammation Research
2026-08-23
T-5224 provides a selective way to interrogate c-Fos/c-Jun AP-1 signaling in cytokine, matrix-remodeling, osteoclast, and extracellular-vesicle assays. This guide translates its established arthritis-research use into a controlled workflow for testing whether inflammatory or tumor-microenvironment signals depend on AP-1, while clearly separating validated findings from exploratory applications.
Metoprolol Tartrate: Reliable β1 Assay Design
2026-08-22
This scenario-based guide explains how Metoprolol Tartrate (SKU B1339) can improve experimental control in β1-adrenergic receptor inhibition, viability, proliferation, and cardiovascular research workflows. It connects formulation data with assay design, interpretation, hematopoietic research, and practical supplier selection.
7-dehydro Cholesterol in DHCR7 Research
2026-08-21
Explore how 7-dehydro Cholesterol connects sterol metabolism, vitamin D3 formation, and DHCR7 biology. This guide translates recent dhcr7 knockout findings into practical assay and experimental-design decisions.
Pol II Degradation and Apoptosis Beyond Transcription
2026-08-21
The reference preprint separates RNA polymerase II degradation from the broader loss of transcription as a driver of cell death. By combining functional-genomic and chemogenetic analyses, it identifies a Pol II degradation-dependent apoptotic response with implications for interpreting transcription-targeting anticancer mechanisms.
Berberrubine and the Vitamin K Cycle in Thrombosis
2026-08-20
The reference study combines mouse thrombosis modeling, untargeted metabolomics, coagulation testing, and molecular docking to investigate how berberrubine hydrochloride suppresses thrombus formation. Its main contribution is a mechanistic link between berberrubine activity and the vitamin K catalytic cycle, while the unchanged bleeding time suggests a potentially useful separation between antithrombotic efficacy and bleeding liability in this model.
459 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page